Type 1 diabetes patients on glucagon show increased satiety

08/22/2013 | Healio

A study in The Journal of Clinical Endocrinology & Metabolism revealed glucagon helped increase satiety in patients with type 1 diabetes and healthy lean participants. However, obese but otherwise healthy participants did not attain such benefits. Researchers said that while therapeutic agents that affect glucagon are considered "a promising avenue for research," the study indicates that treatment with glucagon might not be effective for reducing food consumption in obese people.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA